258 related articles for article (PubMed ID: 19018805)
1. Kynurenine metabolites and inflammation markers in depressed patients treated with fluoxetine or counselling.
Mackay GM; Forrest CM; Christofides J; Bridel MA; Mitchell S; Cowlard R; Stone TW; Darlington LG
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):425-35. PubMed ID: 19018805
[TBL] [Abstract][Full Text] [Related]
2. Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury.
Christofides J; Bridel M; Egerton M; Mackay GM; Forrest CM; Stoy N; Darlington LG; Stone TW
J Neurochem; 2006 May; 97(4):1078-88. PubMed ID: 16573644
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation.
Hughes MM; Carballedo A; McLoughlin DM; Amico F; Harkin A; Frodl T; Connor TJ
Brain Behav Immun; 2012 Aug; 26(6):979-87. PubMed ID: 22683764
[TBL] [Abstract][Full Text] [Related]
4. Kynurenine pathway in major depression: evidence of impaired neuroprotection.
Myint AM; Kim YK; Verkerk R; Scharpé S; Steinbusch H; Leonard B
J Affect Disord; 2007 Feb; 98(1-2):143-51. PubMed ID: 16952400
[TBL] [Abstract][Full Text] [Related]
5. Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery.
Forrest CM; Mackay GM; Oxford L; Millar K; Darlington LG; Higgins MJ; Stone TW
J Neurochem; 2011 Oct; 119(1):136-52. PubMed ID: 21819405
[TBL] [Abstract][Full Text] [Related]
6. Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues.
Kohl C; Walch T; Huber R; Kemmler G; Neurauter G; Fuchs D; Sölder E; Schröcksnadel H; Sperner-Unterweger B
J Affect Disord; 2005 Jun; 86(2-3):135-42. PubMed ID: 15935232
[TBL] [Abstract][Full Text] [Related]
7. Gender based response to fluoxetine hydrochloride medication in endogenous depression.
Bano S; Akhter S; Afridi MI
J Coll Physicians Surg Pak; 2004 Mar; 14(3):161-5. PubMed ID: 15228850
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and immune activation in patients with HIV-infection.
Schroecksnadel K; Sarcletti M; Winkler C; Mumelter B; Weiss G; Fuchs D; Kemmler G; Zangerle R
Brain Behav Immun; 2008 Aug; 22(6):881-9. PubMed ID: 18261883
[TBL] [Abstract][Full Text] [Related]
9. Serotonin transporter is differentially localized in subpopulations of lymphocytes of major depression patients. Effect of fluoxetine on proliferation.
Fazzino F; Montes C; Urbina M; Carreira I; Lima L
J Neuroimmunol; 2008 May; 196(1-2):173-80. PubMed ID: 18462811
[TBL] [Abstract][Full Text] [Related]
10. Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors.
Ploder M; Spittler A; Schroecksnadel K; Neurauter G; Pelinka LE; Roth E; Fuchs D
Clin Sci (Lond); 2009 Apr; 116(7):593-8. PubMed ID: 18986303
[TBL] [Abstract][Full Text] [Related]
11. Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease.
Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D
Thromb Res; 2009 Sep; 124(4):452-7. PubMed ID: 19477487
[TBL] [Abstract][Full Text] [Related]
12. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
13. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
14. Acute deviations from long-term trait depressive symptoms predict systemic inflammatory activity.
Rohleder N; Miller GE
Brain Behav Immun; 2008 Jul; 22(5):709-16. PubMed ID: 18054461
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy.
Pertl MM; Hevey D; Boyle NT; Hughes MM; Collier S; O'Dwyer AM; Harkin A; Kennedy MJ; Connor TJ
Brain Behav Immun; 2013 Nov; 34():108-19. PubMed ID: 23928287
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients.
Mitani H; Shirayama Y; Yamada T; Kawahara R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):531-4. PubMed ID: 16414168
[TBL] [Abstract][Full Text] [Related]
17. Vitamins B2 and B6 as determinants of kynurenines and related markers of interferon-γ-mediated immune activation in the community-based Hordaland Health Study.
Theofylaktopoulou D; Ulvik A; Midttun Ø; Ueland PM; Vollset SE; Nygård O; Hustad S; Tell GS; Eussen SJ
Br J Nutr; 2014 Oct; 112(7):1065-72. PubMed ID: 25105221
[TBL] [Abstract][Full Text] [Related]
18. Altered kynurenine metabolism correlates with infarct volume in stroke.
Darlington LG; Mackay GM; Forrest CM; Stoy N; George C; Stone TW
Eur J Neurosci; 2007 Oct; 26(8):2211-21. PubMed ID: 17892481
[TBL] [Abstract][Full Text] [Related]
19. Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease.
Forrest CM; Mackay GM; Stoy N; Spiden SL; Taylor R; Stone TW; Darlington LG
J Neurochem; 2010 Jan; 112(1):112-22. PubMed ID: 19845828
[TBL] [Abstract][Full Text] [Related]
20. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
Birkenhäger TK; van den Broek WW; Fekkes D; Mulder PG; Moleman P; Bruijn JA
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1084-8. PubMed ID: 17467132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
